10-QFiling Date: Aug 4, 2026

TransMedics (TMDX)

10-Q

View SEC Filing

ACC: 0001193125-26-332843

Key Financial MetricsFY2026 · 2026-06-30

Revenue$189.9M

Net Income$14.7M

Total Assets$1.46B

Stockholders' Equity$518.1M

Operating Cash Flow$41.8M